ALR Technologies SG (ALRTF) EBIAT (2024 - 2025)

ALR Technologies SG posted quarterly EBIAT of -$9.6 million for Q2 2025, down 555.59% year-on-year from $2.1 million in Q2 2024, and down 555.59% on a QoQ basis from -$1.5 million in Q2 2024.

ALR Technologies SG (ALRTF) has 2 years of EBIAT data on file, last reported at -$9.6 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIAT (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.14 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 170.93 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 220.30 Mn
10 ALR Technologies SG - - - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -9.58 Mn
Jun 30, 2024 -1.46 Mn